newsfilter
← Latest News
GlobeNewswire·

Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million

Proceeds to accelerate commercialization of Libmeldy and advance the company's HSC gene therapy R&D portfolio Initial closing of $34 million to support execution and extend cash runway into 2025 with potential for